ReviewCurrent oncology reports2015

Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

Jennifer K Lue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.